# Amphastar Pharmaceuticals, Inc.: Form 8-K, filed Jul 8, 2022

- Company: [Amphastar Pharmaceuticals, Inc.](/companies/amph.md) (CIK 1297184)
- Form: 8-K
- Filed: 2022-07-08
- Accepted by EDGAR: Jul 8, 2022, 16:25 ET
- Period: 2022-07-05
- Accession: 0001297184-22-000036
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1297184/000129718422000036/amph-20220705x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1297184/000129718422000036/

## Items reported

- Item 1.01: Entry into a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1297184/000129718422000036/amph-20220705x8k.htm

Filed Jul 8, 2022.
Source: SEC EDGAR, the filing index for accession 0001297184-22-000036. Last ingested by Listed: Nov 6, 2026, 17:01 ET. No prices; not investment advice.
